Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026)

Updated

Arvinas' Return on Equity [ROE] came in at -1.77% for Q3 2026, up 8.20 percentage points from -9.97% a year earlier but down 3.73 percentage points from the prior quarter.

Analysis

Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Arvinas' Return on Equity [ROE] was -16.23%, up 16.33 percentage points from FY2024.

  • Return on Equity [ROE] carries a five-year change of +10.29 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -32.56% in FY2024 (+27.00 pp), -59.56% in FY2023 (-19.18 pp), -40.38% in FY2022 (-14.52 pp) and -25.86% in FY2021 (+0.66 pp).
  • The five-year range for quarterly Return on Equity [ROE] is -65.31% (Q4 2023) to 1.96% (Q2 2026).
  • Year-over-year, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +19.57 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2025 (a gain of 48.04 percentage points), and the weakest in Q1 2026 (a drop of 46.30 percentage points).
  • Business Quant data shows ARVN's Return on Equity [ROE] at 1.96% (Q2 2026), -53.93% (Q1 2026) and -16.19% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00 -2.27%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.27%
Jun 30, 2026 1.66%
Mar 31, 2026 -54.39%
Dec 31, 2025 -16.15%
Sep 30, 2025 -10.43%
Jun 30, 2025 -10.68%
Mar 31, 2025 -6.66%
Dec 31, 2024 -33.95%
Sep 30, 2024 -49.79%
Jun 30, 2024 -52.07%
Mar 31, 2024 -54.60%
Dec 31, 2023 -62.87%
Sep 30, 2023 -60.75%
Jun 30, 2023 -59.04%
Mar 31, 2023 -54.80%
Dec 31, 2022 -50.07%
Sep 30, 2022 21,546,255.55%
Jun 30, 2022 13,243,367.96%
Mar 31, 2022 5,554,780.90%
Dec 31, 2021 5,226,930.35%
API Access

Arvinas Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARVN&period=max&api_key=YOUR_API_KEY